IBEX: Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Develop AI-based HER2 Scoring Product
Ibex Medical Analytics today announced an agreement with AstraZeneca and Daiichi Sankyo, for the development, clinical validation and early adoption of an AI-powered product to aid pathologists with an accurate and reproducible assessment of HER2 immunohistochemistry (IHC) scoring in breast cancer patients.
Read full article »
Ibex is an Israel-based health-tech platform that provides solutions such as AI-driven cancer diagnostics and data management for the healthcare industry.
Read more